Correlation Between Arch Biopartners and JPMorgan Chase

Can any of the company-specific risk be diversified away by investing in both Arch Biopartners and JPMorgan Chase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arch Biopartners and JPMorgan Chase into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arch Biopartners and JPMorgan Chase Co, you can compare the effects of market volatilities on Arch Biopartners and JPMorgan Chase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arch Biopartners with a short position of JPMorgan Chase. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arch Biopartners and JPMorgan Chase.

Diversification Opportunities for Arch Biopartners and JPMorgan Chase

0.53

Correlation Coefficient

Arch Biopartners  JPMorgan Chase

Very weak diversification

The 3 months correlation between Arch and JPMorgan is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Arch Biopartners and JPMorgan Chase Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JPMorgan Chase and Arch Biopartners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arch Biopartners are associated (or correlated) with JPMorgan Chase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JPMorgan Chase has no effect on the direction of Arch Biopartners i.e., Arch Biopartners and JPMorgan Chase go up and down completely randomly.

Pair Corralation between Arch Biopartners and JPMorgan Chase

Assuming the 90 days trading horizon Arch Biopartners is expected to under-perform the JPMorgan Chase. In addition to that, Arch Biopartners is 1.84 times more volatile than JPMorgan Chase Co. It trades about -0.08 of its total potential returns per unit of risk. JPMorgan Chase Co is currently generating about -0.13 per unit of volatility. If you would invest  3,204  in JPMorgan Chase Co on September 21, 2024 and sell it today you would lose (107.00) from holding JPMorgan Chase Co or give up 3.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.65%
Values	Daily Returns

Arch Biopartners  vs.  JPMorgan Chase Co

Arch Biopartners

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arch Biopartners are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental indicators, Arch Biopartners may actually be approaching a critical reversion point that can send shares even higher in January 2025.

JPMorgan Chase

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, JPMorgan Chase displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Arch Biopartners and JPMorgan Chase

The main advantage of trading using opposite Arch Biopartners and JPMorgan Chase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arch Biopartners position performs unexpectedly, JPMorgan Chase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JPMorgan Chase will offset losses from the drop in JPMorgan Chase's long position.

The idea behind Arch Biopartners and JPMorgan Chase Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.